DermacinRx Lidotral

DermacinRx Lidotral is an FDA drug label for the active ingredient LIDOCAINE HYDROCHLORIDE manufactured by PureTek Corporation administered by TOPICAL. This page reproduces the FDA-approved indications and usage, dosage, contraindications, warnings, and adverse reactions exactly as published in the drug label. Data source: openFDA (U.S. FDA), label effective 20190204.

Generic: LIDOCAINE HYDROCHLORIDE

Manufacturer: PureTek Corporation

Product Type: HUMAN PRESCRIPTION DRUG

Route: TOPICAL

Dosage Form:

NDC: 59088-371

Application:

Effective: 20190204

Indications & Usage

INDICATIONS For the temporary relief of pain and itching associated with minor burns, sunburn, minor cuts, scrapes, insect bites, and minor skin irritation.

Dosage & Administration

DOSAGE AND ADMINISTRATION Apply a thin film to the affected area two or three times daily or as directed by a physician.

Contraindications

CONTRAINDICATIONS Tuberculous or fungal lesions of skin vaccinia, varicella and acute herpes simplex and in persons who have shown hypersensitivity to any of its components. Lidocaine is contraindicated in patients with a known history of hypersensitivity to local anesthetics of the amide type.

Warnings

WARNINGS For external use only. Not for ophthalmic use.

Adverse Reactions

ADVERSE REACTIONS During or immediately after treatment, the skin at the site of treatment may develop erythema or edema or may be the locus of abnormal sensation.

More from same ingredient

Accucaine

Asclemed USA, Inc.

Assured

Zhejiang Jingwei Pharmaceutical Co., Ltd.

Bactine Max Dry

WellSpring Pharmaceutical Corporation

DOCTORS TOUCH Erase The Pain Lidocaine

DOCTOR'S CHOICE MEDICAL, LLC

EBSL-5

Water-Jel Technologies

EBSS-5

Water-Jel Technologies